Human medicines European public assessment report (EPAR): Xiliarx, vildagliptin, Diabetes Mellitus, Type 2, Date of authorisation: 19/11/2008, Revision: 23, Status: Authorised

Development of a reflection paper on modern manufacturing techniques used for herbal preparations - Scientific guideline

Human medicines European public assessment report (EPAR): Nemdatine, memantine, Alzheimer Disease, Date of authorisation: 22/04/2013, Date of refusal: 22/02/2013, Revision: 13, Status: Authorised

Medical Device Shortages Single Point of Contact (SPOC) Working Party

Mandate, objectives and rules of procedure for the Medical Device Shortages SPOC Working Party

Human medicines European public assessment report (EPAR): Amlodipine / Valsartan Mylan , amlodipine,valsartan, Hypertension, Date of authorisation: 22/03/2016, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR): Tobi Podhaler, tobramycin, Cystic Fibrosis;Respiratory Tract Infections, Date of authorisation: 20/07/2011, Revision: 21, Status: Authorised

Human medicines European public assessment report (EPAR): Competact, pioglitazone,metformin, Diabetes Mellitus, Type 2, Date of authorisation: 28/07/2006, Revision: 21, Status: Authorised

Human medicines European public assessment report (EPAR): Caprelsa, vandetanib, Thyroid Neoplasms, Date of authorisation: 16/02/2012, Revision: 52, Status: Authorised